SCHEMBL1122180

SCHEMBL1122180

CC(=O)Nc1ncc(Br)nc1Br

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.38
HSP90AA1 P07900 1/20 0.38
HSP90AB1 P08238 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
CYP1A2 P05177 2/20 0.37
DYRK1A Q13627 3/20 0.36
ATR Q13535 1/20 0.36
PTK2 Q05397 1/20 0.36
ABL1 P00519 1/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
GRM5 P41594 1/20 0.34
RAB9A P51151 2/20 0.33
ALDH1A1 P00352 2/20 0.33
MAPK8 P45983 1/20 0.33
NPC1 O15118 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
CCR4 P51679 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31696340 1.00 KDM4E (0.38) KDM4EHSP90AA1HSP90AB1L3MBTL1CYP1A2
SCHEMBL26174058 0.84 ALDH1A1 (0.39) KDM4EHSP90AA1HSP90AB1L3MBTL1CYP1A2
SCHEMBL29005499 0.84 KDM4E (0.37) KDM4EHSP90AA1HSP90AB1L3MBTL1CYP1A2
SCHEMBL3655719 0.83 ATR (0.41) ATRLMNAGRM5RAB9ANPC1
SCHEMBL21827373 0.82 PTK2 (0.41) KDM4EHSP90AA1HSP90AB1L3MBTL1DYRK1A
SCHEMBL31471197 0.82 PTK2 (0.41) KDM4EHSP90AA1HSP90AB1L3MBTL1DYRK1A
SCHEMBL29522634 0.81 TDP1 (0.38) ATRGRM5
SCHEMBL19387669 0.81 NPSR1 (0.40) KDM4ECYP1A2ATRRAB9AALDH1A1
SCHEMBL7912863 0.81 KDM4E (0.35) KDM4EHSP90AA1HSP90AB1L3MBTL1CYP1A2
SCHEMBL138438 0.79 JAK3 (0.35) ATRLMNAPOLBGRM5ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4724070-A2 WRN INHIBITORS Nimbus Wadjet, Inc. (US) 2026-04-15 EP disclosed
US-12528806-B2 WRN inhibitors NIMBUS WADJET, INC. (US) 2026-01-20 US disclosed
US-12421233-B2 WRN inhibitors NIMBUS WADJET, INC. (US) 2025-09-23 US disclosed
US-12344609-B2 WRN inhibitors NIMBUS WADJET, INC. (US) 2025-07-01 US disclosed
WO-2025137599-A1 WRN INHIBITORS NIMBUS WADJET, INC. (US) 2025-06-26 WO disclosed
US-20250206738-A1 WRN INHIBITORS NIMBUS DISCOVERY, INC. 2025-06-26 US disclosed
US-20250171441-A1 WRN INHIBITORS NIMBUS WADJET, INC. 2025-05-29 US disclosed
US-20250171442-A1 WRN INHIBITORS NIMBUS WADJET, INC. 2025-05-29 US disclosed
US-20250171440-A1 WRN INHIBITORS NIMBUS WADJET, INC. 2025-05-29 US disclosed
US-20250034136-A1 WRN INHIBITORS NIMBUS WADJET, INC. 2025-01-30 US disclosed
WO-2024254511-A2 WRN INHIBITORS NIMBUS WADJET, INC. (US) 2024-12-12 WO disclosed
WO-2023100942-A1 COMPOUND FOR PHOTOOXYGENATION CATALYST AND MEDICINAL COMPOSITION CONTAINING SAME 国立大学法人 東京大学 2023-06-08 WO disclosed
EP-1831184-B1 PYRAZINES AND PYRIDINES AND DERIVATIVES THEREOF AS THERAPEUTIC COMPOUNDS WELLCOME TRUST LTD (GB) 2011-02-09 EP disclosed
US-7737152-B2 6-carboaryl-oxy-pyrazin-2-yl-carboaryl-amines and compositions comprising said compounds THE WELLCOME TRUST LIMITED (GB) 2010-06-15 US disclosed
US-20080015191-A1 Pyrazines and Pyridines and Derivatives Thereof as Therapeutic Compounds THE WELLCOME TRUST LIMITED (UK) 2008-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250206738-A1 WRN INHIBITORS WRN, BLM, RECQL KDM4E 3350/4885HSP90AA1 554/4885HSP90AB1 432/4885
US-20250171440-A1 WRN INHIBITORS WRN, BLM, RECQL KDM4E 2662/4885HSP90AA1 759/4885HSP90AB1 554/4885
US-20250171441-A1 WRN INHIBITORS WRN, BLM, RECQL KDM4E 3350/4885HSP90AA1 554/4885HSP90AB1 432/4885
US-12421233-B2 WRN inhibitors WRN, BLM, RECQL KDM4E 3350/4885HSP90AA1 554/4885HSP90AB1 432/4885
US-12344609-B2 WRN inhibitors WRN, BLM, RECQL KDM4E 2662/4885HSP90AA1 759/4885HSP90AB1 554/4885
US-20080015191-A1 Pyrazines and Pyridines and Derivatives Thereof as Therapeutic Compounds BRAF, RAF1, BCOR KDM4E 2382/4885HSP90AA1 2077/4885HSP90AB1 1638/4885
US-20250034136-A1 WRN INHIBITORS WRN, BLM, RECQL KDM4E 3350/4885HSP90AA1 554/4885HSP90AB1 432/4885
US-20250171442-A1 WRN INHIBITORS WRN, BLM, RECQL KDM4E 3415/4885HSP90AA1 543/4885HSP90AB1 427/4885
US-12528806-B2 WRN inhibitors WRN, RECQL, BLM KDM4E 1099/4885HSP90AA1 1546/4885HSP90AB1 1573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.